|
US5981481A
(en)
*
|
1974-12-06 |
1999-11-09 |
The Johns Hopkins University |
Human C3b/C4b receptor (CR1)
|
|
JPH0742235B2
(ja)
|
1985-11-08 |
1995-05-10 |
三共株式会社 |
自己免疫性疾病の予防・治療剤
|
|
DE3600368C1
(de)
|
1986-01-09 |
1987-04-02 |
Goldschmidt Ag Th |
Trennmittel fuer Polyurethanformteile
|
|
IL89790A
(en)
|
1988-04-01 |
2002-05-23 |
Johns Hopking University |
Nucleic acid sequences that encode and cells that produce cr1 protein and methods of production and purification
|
|
US6458360B1
(en)
|
1990-04-25 |
2002-10-01 |
The Johns Hopkins University |
Soluble complement regulatory molecules
|
|
AU9149791A
(en)
|
1990-12-06 |
1992-07-08 |
T Cell Sciences, Inc. |
Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
|
|
DE69328098T2
(de)
|
1992-06-24 |
2000-08-24 |
Adprotech Plc, Royston |
Lösliche derivate des complement type-rezeptors (cr1)
|
|
GB9301289D0
(en)
|
1993-01-22 |
1993-03-17 |
Smithkline Beecham Plc |
Novel composition
|
|
US5679546A
(en)
|
1993-09-24 |
1997-10-21 |
Cytomed, Inc. |
Chimeric proteins which block complement activation
|
|
US5648244A
(en)
|
1993-09-27 |
1997-07-15 |
President And Fellows Of Harvard College |
Production, purification, cleavage and use of fusion peptides
|
|
AU3066699A
(en)
|
1998-03-03 |
1999-09-20 |
Johns Hopkins University, The |
Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
|
|
AU4452100A
(en)
|
1999-04-09 |
2000-11-14 |
Washington University |
Modified complement system regulators
|
|
EP1218409A2
(en)
|
2000-03-13 |
2002-07-03 |
St. Vincent's Hospital (Melbourne) Limited |
Factor-h related protein 5 (fhr-5) and antibodies thereto
|
|
US20030086940A1
(en)
|
2001-08-10 |
2003-05-08 |
Cristina Costa |
Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
|
|
AU2003282724B2
(en)
|
2002-10-02 |
2010-03-04 |
Catalyst Biosciences, Inc. |
Methods of generating and screening for proteases with altered specificity
|
|
US20060140939A1
(en)
|
2003-02-21 |
2006-06-29 |
Fung Sek C M |
Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
|
|
WO2004075838A2
(en)
|
2003-02-21 |
2004-09-10 |
Rikshospitalet-Radiumhospitalet Hf |
Method and compositions for the treatment of meconium aspiration syndrome
|
|
EP2266606B1
(en)
|
2003-05-15 |
2014-09-10 |
Genentech, Inc. |
Methods and compositions for the prevention and treatment of sepsis
|
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
|
US20050112139A1
(en)
|
2003-10-23 |
2005-05-26 |
Nmk Research, Llc |
Immunogenic composition and method of developing a vaccine based on factor H binding sites
|
|
WO2005069726A2
(en)
*
|
2004-01-21 |
2005-08-04 |
Case Western Reserve University |
Hybrid and chimeric polypeptides that regulate activation of complement
|
|
JP2005211063A
(ja)
|
2004-01-30 |
2005-08-11 |
Junko Maekuroshima |
ブレンドノニ茶
|
|
US20050169921A1
(en)
|
2004-02-03 |
2005-08-04 |
Leonard Bell |
Method of treating hemolytic disease
|
|
US20050277158A1
(en)
|
2004-06-10 |
2005-12-15 |
Ge Chen |
Method and kit for donor specific complement-fixing antibodies crossmatch
|
|
WO2006012373A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
US7745389B2
(en)
|
2005-02-14 |
2010-06-29 |
University Of Iowa Research Foundation |
Methods for treatment of age-related macular degeneration
|
|
EP1879610A1
(en)
|
2005-05-06 |
2008-01-23 |
Laboratoires Serono S.A. |
Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
|
|
JP5219819B2
(ja)
|
2005-10-21 |
2013-06-26 |
カタリスト・バイオサイエンシーズ・インコーポレイテッド |
補体活性化を阻害する修飾プロテアーゼ
|
|
SG10201804008UA
(en)
|
2005-11-04 |
2018-06-28 |
Genentech Inc |
Use of complement pathway inhibitors to treat ocular diseases
|
|
US7759304B2
(en)
|
2006-06-21 |
2010-07-20 |
Regents Of The University Of Colorado |
Targeting complement factor H for treatment of diseases
|
|
WO2008005455A2
(en)
|
2006-07-03 |
2008-01-10 |
The Johns Hopkins University |
Peptide antibody depletion and its application to mass spectrometry sample preparation
|
|
EP2479284B1
(en)
|
2006-07-13 |
2017-09-20 |
University of Iowa Research Foundation |
Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
|
|
CA2666843C
(en)
|
2006-10-20 |
2015-06-16 |
Celldex Therapeutics, Inc. |
Treatment of age-related macular degeneration and other diseases of the eye
|
|
TW201716437A
(zh)
|
2006-11-02 |
2017-05-16 |
建南德克公司 |
人類化之抗-因子ｄ抗體及其用途
|
|
GB0701213D0
(en)
|
2007-01-23 |
2007-02-28 |
Univ Cardiff |
Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
|
|
JP5332064B2
(ja)
|
2007-03-01 |
2013-11-06 |
ウェルスタット イムノセラピューティクス， エルエルシー |
炎症により特徴付けられる疾患の治療
|
|
GB2447696A
(en)
|
2007-03-23 |
2008-09-24 |
Univ Exeter |
Photonic biosensor arrays
|
|
GB2447698A
(en)
|
2007-03-23 |
2008-09-24 |
Univ Exeter |
Fabrication of photonic biosensor arrays
|
|
RU2473563C2
(ru)
*
|
2007-06-07 |
2013-01-27 |
Дженентек, Инк. |
АНТИТЕЛА ПРОТИВ C3b И СПОСОБЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СВЯЗАННЫХ С КОМПЛЕМЕНТОМ НАРУШЕНИЙ
|
|
WO2009022246A1
(en)
|
2007-08-10 |
2009-02-19 |
Koninklijke Philips Electronics N.V. |
Sensor array for spr-based detection.
|
|
WO2009059321A2
(en)
|
2007-11-01 |
2009-05-07 |
University Of Iowa Research Foundation |
Rca locus analysis to assess susceptibility to amd and mpgnii
|
|
CL2008003241A1
(es)
|
2007-11-02 |
2009-07-31 |
Novartis Ag |
Molecula de enlace que comprende una porcion de enlace de antigeno que se enlaza con un neoepitopo de c3b; composicion farmaceutica que la comprende; y su uso para tratar trastornos oculares
|
|
US20110190221A1
(en)
|
2008-03-28 |
2011-08-04 |
Apellis Ag |
Modulation and repletion/enhancement of the complement system for treatment of trauma
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
WO2009151634A1
(en)
|
2008-06-12 |
2009-12-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
|
|
WO2010027872A1
(en)
|
2008-08-27 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Complement factor h-based assays for serum bactericidal activity against neisseria meningitidis
|
|
GB0815576D0
(en)
|
2008-08-28 |
2008-10-01 |
Lucas & Co |
Analysis of glycated proteins
|
|
US8937046B2
(en)
|
2008-09-22 |
2015-01-20 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
|
CA2742802C
(en)
|
2008-11-10 |
2019-11-26 |
Alexion Pharmaceuticals, Inc. |
Methods and compositions for treating complement-associated disorders
|
|
WO2010056399A1
(en)
|
2008-11-17 |
2010-05-20 |
Incode Biopharmaceutics, Inc. |
Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
|
|
DK2488203T3
(en)
|
2009-10-16 |
2017-03-13 |
Omeros Corp |
METHODS OF TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITION OF MASP-2 DEPENDENT COMPLEMENT ACTIVATION
|
|
CA2795311A1
(en)
|
2009-11-05 |
2011-05-12 |
Taligen Therapeutics, Inc. |
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
|
|
GB0922659D0
(en)
|
2009-12-24 |
2010-02-10 |
Univ Edinburgh |
Factor H
|
|
ES2615732T3
(es)
|
2010-03-01 |
2017-06-08 |
Alexion Pharmaceuticals, Inc. |
Composiciones para tratar la enfermedad de Degos
|
|
US9815876B2
(en)
|
2010-03-05 |
2017-11-14 |
Omeros Corporation |
Chimeric inhibitor molecules of complement activation
|
|
WO2011130844A1
(en)
|
2010-04-22 |
2011-10-27 |
Patricia Marlen Nieva |
Method and apparatus for an interferometric localized surface plasmon resonance (ilspr) sensor
|
|
BR112012029067A2
(pt)
|
2010-05-14 |
2019-09-24 |
Univ Colorado Regents |
grupos-alvo de receptor do complemento 2 (cr2) melhorados.
|
|
SG186397A1
(en)
|
2010-06-22 |
2013-01-30 |
Univ Colorado Regents |
Antibodies to the c3d fragment of complement component 3
|
|
AU2011301996A1
(en)
|
2010-09-15 |
2013-03-21 |
Celldex Therapeutics, Inc. |
Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)
|
|
BR112013010769A2
(pt)
|
2010-11-01 |
2019-09-24 |
Genentech Inc |
predição de progressão para degeneração macular relacionada à idade avançada usando um escore poligênico
|
|
WO2012095519A1
(en)
|
2011-01-13 |
2012-07-19 |
Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie |
Potent inhibitors of complement activation
|
|
BR112013025917A2
(pt)
|
2011-04-08 |
2016-12-20 |
Omeros Corp |
uso de um anticorpo masp-2 ou fragmento do mesmo que inibe ativação de complemento dependente de masp-2
|
|
ES2651521T3
(es)
*
|
2011-12-01 |
2018-01-26 |
Innovent Biologics, Inc. |
Inhibidores proteicos de las rutas del complemento y de VEGF y métodos de uso de los mismos
|
|
WO2013151665A2
(en)
*
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
EP2858679B2
(en)
|
2012-06-08 |
2024-06-05 |
Translate Bio, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
|
EP4331620A3
(en)
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
HK1218300A1
(zh)
|
2013-01-23 |
2017-02-10 |
Musc Foundation For Research Development |
基於天然抗體的靶向結構體及其應用
|
|
GB201301632D0
(en)
|
2013-01-30 |
2013-03-13 |
Imp Innovations |
Complement System
|
|
IL288931B2
(en)
|
2013-03-14 |
2025-05-01 |
Alnylam Pharmaceuticals Inc |
Compositions comprising a complementary portion of C5 IRNA and methods of using them
|
|
WO2014194213A1
(en)
|
2013-05-30 |
2014-12-04 |
University Of Iowa Research Foundation |
Specific complement proteins and efficacy of antibody therapy
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
CA2920293A1
(en)
|
2013-08-16 |
2015-02-19 |
Alexion Pharmaceuticals, Inc. |
Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant
|
|
CN104231085B
(zh)
|
2013-09-05 |
2017-03-15 |
复旦大学附属肿瘤医院 |
靶向特异性补体系统抑制剂、其制备方法及应用
|
|
GB201318170D0
(en)
|
2013-10-14 |
2013-11-27 |
Univ Edinburgh |
Proteins with Diagnostic and Therapeutic Uses
|
|
ES3032935T3
(en)
|
2013-10-22 |
2025-07-29 |
Translate Bio Inc |
Lipid formulations for delivery of messenger rna
|
|
FR3015484A1
(fr)
*
|
2013-12-20 |
2015-06-26 |
Lab Francais Du Fractionnement |
Proteines recombinantes possedant une activite de facteur h
|
|
US20180085391A1
(en)
|
2014-08-08 |
2018-03-29 |
Modernatx, Inc. |
Compositions and methods for the treatment of ophthalmic diseases and conditions
|
|
CN107074939B
(zh)
|
2014-08-20 |
2021-09-07 |
桑昆血液供给基金会 |
H因子增强抗体及其用途
|
|
WO2016068616A1
(ko)
|
2014-10-29 |
2016-05-06 |
차의과학대학교 산학협력단 |
C3 또는 c1r 보체를 분비하는 태반 유래 세포 및 이를 포함하는 조성물
|
|
US20210318287A1
(en)
|
2015-02-16 |
2021-10-14 |
The Regents Of The University Of Michigan |
Localized surface plasmon resonance sensor systems and methods
|
|
SG11201706840WA
(en)
|
2015-03-31 |
2017-09-28 |
Vhsquared Ltd |
Peptide construct having a protease-cleavable linker
|
|
CN108291216B
(zh)
*
|
2015-09-24 |
2022-09-16 |
宾夕法尼亚州大学信托人 |
用于治疗补体介导的疾病的组合物和方法
|
|
KR20240005973A
(ko)
|
2016-04-15 |
2024-01-12 |
리젠엑스바이오 인크. |
완전히-인간형의 번역후 변형된 항-VEGF Fab를 이용한 눈 질환의 치료
|
|
GB201608046D0
(en)
*
|
2016-05-09 |
2016-06-22 |
Cambridge Entpr Ltd And Syndey Children S Hospitals Network Randwick And Westmead Incorporating The |
Treatment of complement-mediated disorders
|
|
CA3029106A1
(en)
*
|
2016-06-28 |
2018-01-04 |
Universitat Ulm |
Complement inhibitors and uses thereof
|
|
GB201709222D0
(en)
*
|
2017-06-09 |
2017-07-26 |
Univ Manchester |
C3b Inactivating Polypeptide
|
|
US11442067B2
(en)
|
2017-07-25 |
2022-09-13 |
Biocon Limited |
Peptide mapping method for sequence identification of insulin and insulin analogues
|
|
GB201800620D0
(en)
|
2018-01-15 |
2018-02-28 |
Univ Manchester |
C3b Binding Polypeptide
|
|
KR102775717B1
(ko)
|
2018-03-13 |
2025-03-06 |
암젠 인크 |
질량 분광 분석을 위한 폴리펩티드의 순차적 소화
|
|
WO2019215330A1
(en)
|
2018-05-10 |
2019-11-14 |
The University Of Manchester |
Methods for assessing macular degeneration
|
|
CA3100071A1
(en)
|
2018-05-16 |
2019-11-21 |
Csl Limited |
Soluble complement receptor type 1 variants and uses thereof
|
|
GB2583560A
(en)
|
2018-12-11 |
2020-11-04 |
Admirx Inc |
Fusion protein constructs for complement associated disease
|
|
GB201821082D0
(en)
|
2018-12-21 |
2019-02-06 |
Gyroscope Therapeutics Ltd |
Combination of complement factors i and h, and vector encoding thereof
|
|
KR20220019806A
(ko)
|
2019-06-12 |
2022-02-17 |
씨에스엘 이노베이션 피티와이 엘티디 |
가용성 보체 수용체 1형 변이체 접합체 및 이의 용도
|
|
GB202006789D0
(en)
|
2020-05-07 |
2020-06-24 |
Univ Manchester |
Detection of complement proteins
|
|
GB202007353D0
(en)
|
2020-05-18 |
2020-07-01 |
Shaw Andrew |
Viral infection characterization
|
|
US20210373009A1
(en)
|
2020-05-28 |
2021-12-02 |
University Of North Texas |
Plasmonic meta-surface based molecular sensors and methods for making and using them
|
|
CR20230202A
(es)
|
2020-10-16 |
2023-06-13 |
Gyroscope Therapeutics Ltd |
Ácido nucleico que codifica una entidad anti-vegf y un regulador del complemento negativo y sus usos para el tratamiento de la degeneración macular relacionada con la edad
|